Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetLaurent Peyrin‐Biroulet, Remo Panaccione, Robert H. Riddell et al.|The American Journal of Gastroenterology|2015Cited by 1.8k
Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel diseaseAlba Garrido-Trigo, Azucena Salas, A M Corraliza et al.|Nature Communications|2023Cited by 280
Dissecting Common and Unique Effects of Anti-α4β7 and Anti-Tumor Necrosis Factor Treatment in Ulcerative ColitisMarisol Veny, Azucena Salas, Alba Garrido-Trigo et al.|Journal of Crohn s and Colitis|2020Cited by 29
Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patientsElisa Melón-Ardanaz, Azucena Salas, Marisol Veny et al.|Journal of Crohn s and Colitis|2025Cited by 10
Understanding the mechanisms underlying the lack of response to Janus kinase inhibition in ulcerative colitisElisa Melón-Ardanaz, Azucena Salas, Marisol Veny et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 4